# Nicotine Lozenge to Reduce Smokeless Tobacco Use

> **NCT00218283** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 100 (actual)

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **DRUG:** Nicotine Lozenge
- **BEHAVIORAL:** Behavioral Counseling

## Key facts

- **NCT ID:** NCT00218283
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218283, "Nicotine Lozenge to Reduce Smokeless Tobacco Use". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00218283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*